ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $349,000 | +44.8% | 2,029 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $241,000 | -71.8% | 1,924 | -69.5% | 0.00% | -75.0% |
| Q1 2021 | $854,000 | +3.8% | 6,299 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $823,000 | +13.7% | 6,431 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $724,000 | +17.3% | 6,431 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $617,000 | +52.3% | 6,479 | +43.8% | 0.00% | +33.3% |
| Q1 2020 | $405,000 | +84.1% | 4,506 | -46.0% | 0.00% | -50.0% |
| Q1 2016 | $220,000 | -41.2% | 8,350 | +8.8% | 0.01% | -40.0% |
| Q4 2015 | $374,000 | +47.8% | 7,673 | -24.4% | 0.01% | +42.9% |
| Q3 2015 | $253,000 | -99.9% | 10,150 | +13.4% | 0.01% | +16.7% |
| Q2 2015 | $283,178,000 | +110950.2% | 8,950 | +33.5% | 0.01% | +20.0% |
| Q1 2015 | $255,000 | – | 6,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |